Los Angeles Capital Management
CGON icon

Los Angeles Capital Management’s CG Oncology CGON Stock Holding History

Los Angeles Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.8K Sell
159
-10
-6% -$567 ﹤0.01% 1935
2025
Q4 		$7.18K Buy
+169
New +$6.99K ﹤0.01% 2198
2025
Q3 		– Sell
-11,197
Closed -$291K – 1381
2025
Q2 		$291K Sell
11,197
-16,325
-59% -$393K ﹤0.01% 1062
2025
Q1 		$674K Sell
27,522
-2,675
-9% -$75.2K ﹤0.01% 680
2024
Q4 		$866K Buy
30,197
+8,145
+37% +$279K ﹤0.01% 664
2024
Q3 		$832K Buy
+22,052
New +$773K ﹤0.01% 705

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Los Angeles Capital Management's CGON Position: Q1 2026 in Review

Los Angeles Capital Management reduced its CG Oncology (CGON) stake by 5.9% in Q1 2026, selling an estimated $567 and leaving 159 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1935.

Los Angeles Capital Management first reported a position in CGON in Q3 2024 and has held it in 6 quarters since. The position peaked at $866K in Q4 2024. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Los Angeles Capital Management held 159 shares of CG Oncology worth $10.8K as of Q1 2026.
  • Los Angeles Capital Management sold 10 CG Oncology shares in Q1 2026, an estimated $567.
  • CG Oncology made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1935 holding.
  • Los Angeles Capital Management first reported a position in CG Oncology in Q3 2024 and has held it in 6 quarters since.
  • Los Angeles Capital Management's CG Oncology position peaked at $866K in Q4 2024.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.